Pacira BioSciences Inc (PCRX)
17.56
+0.18
(+1.04%)
USD |
NASDAQ |
Nov 22, 09:55
Pacira BioSciences Shareholders Equity (Quarterly): 749.58M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 749.58M |
June 30, 2024 | 879.28M |
March 31, 2024 | 892.16M |
December 31, 2023 | 870.13M |
September 30, 2023 | 831.55M |
June 30, 2023 | 807.98M |
March 31, 2023 | 768.04M |
December 31, 2022 | 775.01M |
September 30, 2022 | 770.12M |
June 30, 2022 | 756.64M |
March 31, 2022 | 709.58M |
December 31, 2021 | 730.41M |
September 30, 2021 | 718.60M |
June 30, 2021 | 687.17M |
March 31, 2021 | 650.82M |
December 31, 2020 | 619.69M |
September 30, 2020 | 584.69M |
June 30, 2020 | 388.15M |
March 31, 2020 | 374.04M |
December 31, 2019 | 354.94M |
September 30, 2019 | 346.16M |
June 30, 2019 | 341.65M |
March 31, 2019 | 327.52M |
December 31, 2018 | 321.23M |
September 30, 2018 | 301.27M |
Date | Value |
---|---|
June 30, 2018 | 290.51M |
March 31, 2018 | 278.52M |
December 31, 2017 | 279.48M |
September 30, 2017 | 264.80M |
June 30, 2017 | 261.05M |
March 31, 2017 | 270.63M |
December 31, 2016 | 218.98M |
September 30, 2016 | 214.15M |
June 30, 2016 | 228.35M |
March 31, 2016 | 226.17M |
December 31, 2015 | 218.39M |
September 30, 2015 | 209.01M |
June 30, 2015 | 195.28M |
March 31, 2015 | 184.02M |
December 31, 2014 | 171.14M |
September 30, 2014 | 155.07M |
June 30, 2014 | 147.97M |
March 31, 2014 | 35.71M |
December 31, 2013 | 41.25M |
September 30, 2013 | 49.12M |
June 30, 2013 | 59.14M |
March 31, 2013 | 69.79M |
December 31, 2012 | 65.86M |
September 30, 2012 | 80.44M |
June 30, 2012 | 94.50M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
354.94M
Minimum
Dec 2019
892.16M
Maximum
Mar 2024
695.93M
Average
740.00M
Median
Shareholders Equity (Quarterly) Benchmarks
Cyclo Therapeutics Inc | -13.47M |
NovaBay Pharmaceuticals Inc | 1.072M |
Palatin Technologies Inc | -7.686M |
iBio Inc | 17.75M |
Theriva Biologics Inc | 24.64M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 1.522B |
Total Liabilities (Quarterly) | 772.11M |
Debt to Equity Ratio | 0.7836 |
Current Ratio | 2.252 |
Net Debt Paydown Yield | -1.03% |